Square Pharmaceuticals PLC. announcements
313 Dhaka Stock Exchange announcements for Square Pharmaceuticals PLC. (SQURPHARMA) since 2007: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2012 (17).
- HY Earnings 2012
<span style="text-align: justify; ">As per un-audited half yearly accounts as on 30.09.2012 (April'12 to Sep'12), the Company has reported consolidated profit after tax (excluding non controlling interest) of Tk. 2,050.76 million with consolidated EPS of Tk. 5.53 as against Tk. 2,023.12 million and Tk. 5.46 respectively for the same period of the previous year. Whereas consolidated profit after tax (excluding non controlling interest) was Tk. 1,067.78 million with consolidated EPS of Tk. 2.88 for the period of 3 months (July'12 to Sep'12) ended on 30.09.2012 as against Tk. 1,048.32 million and Tk. 2.83 respectively for the same period of the previous year.</span> <p class="MsoNormal" style="text-align:justify"><o:p></o:p>
- (H/Y): As per un-audited half yearly accounts as on 30.09.2012 (April'12 to Sep'12), the Company has reported consolidat
(H/Y): As per un-audited half yearly accounts as on 30.09.2012 (April'12 to Sep'12), the Company has reported consolidated profit after tax (excluding non controlling interest) of Tk. 2,050.76 million with consolidated EPS of Tk. 5.53 as against Tk. 2,023.12 million and Tk. 5.46 respectively for the same period of the previous year. Whereas consolidated profit after tax (excluding non controlling interest) was Tk. 1,067.78 million with consolidated EPS of Tk. 2.88 for the period of 3 months (July'12 to Sep'12) ended on 30.09.2012 as against Tk. 1,048.32 million and Tk. 2.83 respectively for the same period of the previous year.
- The Company has informed that it has credited the bonus shares for the year 2011-2012 to the respective shareholders' BO
The Company has informed that it has credited the bonus shares for the year 2011-2012 to the respective shareholders' BO Accounts on October 02, 2012.
- Normal trading of the shares of the Company will resume on 27.08.2012 after record date.
Normal trading of the shares of the Company will resume on 27.08.2012 after record date.
- Trading of the shares of the Company will remain suspended on record date i.e., 26.08.2012.
Trading of the shares of the Company will remain suspended on record date i.e., 26.08.2012.
- (Q1): As per un-audited quarterly accounts for the 1st quarter ended on 30th June 2012 (Apr'12 to June'12), the Company
(Q1): As per un-audited quarterly accounts for the 1st quarter ended on 30th June 2012 (Apr'12 to June'12), the Company has reported consolidated profit after tax (excluding non-controlling interest) of Tk. 982.98 million with consolidated basic EPS of Tk. 3.71 as against Tk. 974.80 million and Tk. 3.68 respectively for the same period of the previous year. However, considering proposed bonus share @ 40% for the year 2012, consolidated restated basic EPS will be Tk. 2.65 as on 30.06.12 and Tk. 2.63 as on 30.06.11.
- Trading of the shares of the Company will be allowed only in the Spot Market and Block/Odd lot transactions will also be
Trading of the shares of the Company will be allowed only in the Spot Market and Block/Odd lot transactions will also be settled as per Spot settlement cycle with cum benefit from 12.08.2012 to 14.08.2012. Trading of the shares of the Company will remain suspended on record date i.e., 26.08.2012.
- There will be no price limit on the trading of the shares of the Company today (23.07.2012) following its corporate decl
There will be no price limit on the trading of the shares of the Company today (23.07.2012) following its corporate declaration.
- The Board of Directors has recommended cash dividend @ 25% (i.e. Tk. 2.50 per share of Tk. 10.00 each) and stock dividen
The Board of Directors has recommended cash dividend @ 25% (i.e. Tk. 2.50 per share of Tk. 10.00 each) and stock dividend @ 40% for the year ended on March 31, 2012. Date of AGM: 25.09.2012, Time: 11:00 AM, Venue: Factory premises, Kaliakoir, Gazipur. Record Date: 26.08.2012. The Company has also reported NAV of Tk. 16,266.88 million, EPS of Tk. 10.94 and NOCFPS of Tk. 13.76 for the year ended on March 31, 2012.
- As per regulation 30 of DSE Listing Regulations, the Company has informed that a meeting of Board of Directors of the Co
As per regulation 30 of DSE Listing Regulations, the Company has informed that a meeting of Board of Directors of the Company will be held on July 22, 2012 at 3:00 p.m. to consider, among others, audited financial statements of the Company for the year ended on March 31, 2012.
- - The Credit Rating Information ...
The Credit Rating Information and Services Limited (CRISL) has rated the Company as "AA+" in the long term and "ST-1" in the short term in consideration of audited financials of the Company up to March 31, 2011 and other relevant quantitative as well as qualitative information up to the date of rating declaration.
- The Credit Rating Information and Services Limited (CRISL) has rated the Company as "AA+" in the long term and "ST-1" in
The Credit Rating Information and Services Limited (CRISL) has rated the Company as "AA+" in the long term and "ST-1" in the short term in consideration of audited financials of the Company up to March 31, 2011 and other relevant quantitative as well as qualitative information up to the date of rating declaration.
- The Company has informed that a total of 3,93,57,870 shares of Late Samson H Chowdhury, the founder Chairman of Square P
The Company has informed that a total of 3,93,57,870 shares of Late Samson H Chowdhury, the founder Chairman of Square Pharmaceuticals Ltd., has been transmitted to his legal heirs (wife, sons and daughter, all are Sponsors/Directors of the Company) in the following manner according to the Succession Certificate issued by the Honorable Court: (a) 1,31,19,290 shares to Mrs. Anita Chowdhury, (b) 65,59,645 shares to Mr. Samuel S Chowdhury, (c) 65,59,645 shares to Mr. Tapan Chowdhury, (d) 65,59,645 shares to Mr. Anjan Chowdhury and (e) 65,59,645 shares to Mrs. Ratna Patra.
- The Company has informed that the Board of Directors of the Company has elected Mr. Samuel S Chowdhury as Chairman and M
The Company has informed that the Board of Directors of the Company has elected Mr. Samuel S Chowdhury as Chairman and Mrs. Ratna Patra as Vice Chairman of the Company.
- (continuation of news of SQURPHARMA-Q3 ) Again, As per un-audited quarterly accounts for the 3rd quarter ended on 31st D
(continuation of news of SQURPHARMA-Q3 ) Again, As per un-audited quarterly accounts for the 3rd quarter ended on 31st December 2011 (Oct'11 to Dec'11), the Company has reported profit after tax of Tk. 764.85 million with EPS of Tk. 2.89 as against Tk. 683.73 million and Tk. 2.58 respectively for the same period of the previous year. Whereas profit after tax was Tk. 2,516.58 million with EPS of Tk. 9.50 for the period of nine months (Apr'11 to Dec'11) ended on 31.12.11 as against Tk. 2,182.54 million and Tk. 8.24 respectively for the same period of the previous year. (end).
The first part of this announcement is missing from the archive. - (Q3): As per un-audited quarterly accounts for the 3rd quarter ended on 31st December 2011 (Oct'11 to Dec'11), the Compa
(Q3): As per un-audited quarterly accounts for the 3rd quarter ended on 31st December 2011 (Oct'11 to Dec'11), the Company has reported Consolidated profit after tax and non controlling interest of Tk. 945.52 million with Consolidated EPS of Tk. 3.57 as against Tk. 850.35 million and Tk. 3.21 respectively for the same period of the previous year. Whereas Consolidated profit after tax and non controlling interest was Tk. 2,968.64 million with Consolidated EPS of Tk. 11.21 for the period of nine months (Apr'11 to Dec'11) ended on 31.12.11 as against Tk. 2,660.74 million and Tk. 10.05 respectively for the same period of the previous year. (cont.)
- Mr. Anjan Chowdhury, Mr. Tapan Chowdhury, Mr. Samuel S Chowdhury and Mrs. Ratna Patra, all are Sponsors/Directors of the
Mr. Anjan Chowdhury, Mr. Tapan Chowdhury, Mr. Samuel S Chowdhury and Mrs. Ratna Patra, all are Sponsors/Directors of the Company, have further reported that they have completed their buy of 25,000 shares each at prevailing market price through Stock Exchange as announced earlier.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.